# Telomere Beauty Laser

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/telomere-beauty-laser

- Industry: Healthcare
- Headquarters: Shaoxing, China
- Website: www.dlmlaser.com
- Latest round: Series A (Jan 21, 2026)
- Investors on record: 1

## About

Telomere Beauty Laser is a Chinese company focused on developing innovative femtosecond laser technology for aesthetic and medical treatments, aimed at enhancing skin health and beauty through advanced laser applications.Founded in 2022 and headquartered in Shaoxing, China, Telomere Beauty Laser specializes in medical aesthetic laser technology. The company has completed 1 deal as of January 2026, marking its entry into the market without reported changes in business strategy. The founder's background is not detailed in available information.Telomere Beauty Laser specializes in the development and application of advanced femtosecond laser technology for medical and aesthetic treatments. Its flagship device utilizes a stable energy source to deliver ultra-short laser pulses, effectively addressing skin concerns such as rejuvenation, anti-aging, pigmentation removal, and sensitive skin repair. This technology promises precision with minimal thermal damage, ensuring faster recovery times. The company primarily markets its products to dermatology clinics, cosmetic surgery practices, and wellness centers across Europe, North America, and Asia.The revenue model is based on direct sales of advanced medical devices to healthcare professionals. Telomere Beauty Laser engages in B2B transactions with clinics and cosmetic surgeons, providing femtosecond laser treatment devices. Pricing is structured around device acquisition and includes service agreements for maintenance and training. The company is expanding its product line through ongoing research and development to include additional devices such as laser acupuncture instruments and skin workstations, which are expected to enhance revenue generation.Telomere Beauty Laser plans to utilize the funds raised in January 2026, during its Series A funding round from new investor Xinghua Dingli Capital, to advance product development and clinical applications. The company is focusing on designing and launching new products, with a particular emphasis on expanding its offerings in laser technology. Specific markets targeted for expansion include further penetration into Europe and North America by mid-2026.

## Funding rounds

- Series A, Jan 21, 2026 — Xinghua Dingli Capital

## Investors

- Xinghua Dingli Capital (https://capitalatlas.ai/funds/xinghua-dingli-capital) — Series A